- Legal Expert News
- Law Firm News
- Career News
- Headline Legal News
- Legal Trend News
- Legal Business
- Local Court News
- Court Watch
- Legal Interview
- Topics in Legal News
- Press Release
- Politics & Legal
- Market News
- Courts: Bail reform working, but sustainable funding needed
- Catalan politicians in Spanish court in secession probe
- Supreme Court blocks some redrawn North Carolina districts
- Court allows Pennsylvania to redraw GOP-favored district map
- Court rules that Kushner firm must disclose partners' names
- Court rules Puigdemont must return to Spain for re-election
- Analysis: Outside groups may factor in Arkansas court race
- Pennsylvania GOP take gerrymandering case to US high court
- Top Pakistani court orders arrest of escaped police officer
- Malaysia's top court annuls unilateral conversions of minors
Trasylol has been marketed by Bayer for 14 years. Bayer marketed it aggressively until it was used in approximately 1/3 of all cardiac bypass surgeries. In the last two years, Trasylol has been linked to kidney or renal failure, heart attacks, strokes and approximately 22,000 deaths.
At the heart of current and pending litigation surrounding Trasylol side effects, is the fact that Bayer was aware of the potential problems over two years ago. A study connecting Trasylol and serious side effects was presented in January 2006, but the drug was not recalled until November 2007. Bayer failed to present their research to the FDA in their September 2006 meeting. The chairman of that FDA advisory panel, Dr. William Hiatt, said that he would have voted for a Trasylol recall back in 2006 if Bayer had not withheld the data from their study.
Michael E. Schmidt, Managing Partner of Schmidt & Clark, LLP has noticed an alarming number of inquiries to the firm related to Trasylol. Mr. Schmidt stated, “Our firm has substantial expertise in the areas drug litigation. As a result, we have received a number of inquiries from heart bypass surgery patients claiming serious or life-threatening side effects including death, kidney or renal failure, heart attacks, and strokes.”
Schmidt & Clark, LLP represents a number of Trasylol recall victims and continues to be contacted by victims of Trasylol on a frequent basis.
If you or a loved one has been the victim of a Trasylol induced side effect, the firm suggests that you visit their Trasylol website. The site includes detailed lawsuit information, news and more.
About Schmidt & Clark, LLP
Schmidt & Clark, LLP focuses on helping individuals and families. The firm has built a reputation for success, and represents their clients in group and individual lawsuits nationwide.
Although Schmidt & Clark, LLP is national in scope, they level the playing field for their clients by providing them with access to a level of professional legal representation previously available only to large corporations, while still providing personal attention to each client.
For more information on Schmidt & Clark, LLP or Trasylol lawsuits, please visit: http://www.schmidtandclark.com/Trasylol/ or call toll free 24 hrs/day (866) 588-0600.
Legal News Media
Legal News is the top headline legal news provider for lawyers and legalprofessionals. Read law articles and breaking news from law firm's across the United States to get the latest updates. We reserve the right, at our discretion, to change, modify, add, or remove portions of the site at any time. Your This site is solely for your personal use. You are, of course, welcome to print or otherwise copy material from this site for your personal use. However, you may not distribute, exchange, modify, sell or transmit anything you copy from this Site, including but not limited to any text, images, audio and video, for any business, commercial or public purpose. Any unauthorized use of the text, images, audio and video may violate copyright laws, trademark laws, the laws of privacy and publicity and civil and criminal statutes.